|
US3009864A
(en)
|
1958-09-18 |
1961-11-21 |
Union Carbide Corp |
Process control
|
|
US3228838A
(en)
|
1959-04-23 |
1966-01-11 |
Union Carbide Corp |
Preservation of biological substances
|
|
US3009861A
(en)
|
1961-01-13 |
1961-11-21 |
Alderton Gordon |
Isolation of bacterial spores
|
|
US3608030A
(en)
|
1969-05-21 |
1971-09-21 |
Howard Tint |
Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
|
|
US4077227A
(en)
|
1976-11-12 |
1978-03-07 |
Regents Of The University Of Minnesota |
Method of freezing liquid material in which agglomeration is inhibited
|
|
US4205132A
(en)
|
1978-07-17 |
1980-05-27 |
Microlife Technics, Inc. |
Lyophilization of bacteria
|
|
FI59925C
(fi)
|
1980-01-11 |
1981-11-10 |
Esko Viljo Nurmi |
Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
|
|
US4655047A
(en)
|
1985-03-25 |
1987-04-07 |
I.Q.F. Inc. |
Process for freezing or chilling
|
|
JPS61252212A
(ja)
|
1985-04-12 |
1986-11-10 |
Mitsubishi Petrochem Co Ltd |
高吸水性ポリマ−の製造方法
|
|
US4839281A
(en)
|
1985-04-17 |
1989-06-13 |
New England Medical Center Hospitals, Inc. |
Lactobacillus strains and methods of selection
|
|
WO1989003219A1
(en)
|
1987-10-12 |
1989-04-20 |
Borody Thomas J |
Improved method for treatment of gastrointestinal disorders
|
|
US5045446A
(en)
|
1988-08-26 |
1991-09-03 |
Cryopharm Corporation |
Lyophilization of cells
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
WO1990001335A1
(en)
*
|
1988-08-02 |
1990-02-22 |
Borody Thomas J |
Treatment of gastro-intestinal disorders
|
|
GB2233343B
(en)
|
1989-06-30 |
1993-07-07 |
Farmos Oy |
A bacterial preparation for use in poultry
|
|
JP2961182B2
(ja)
|
1990-03-09 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
US5436002A
(en)
|
1991-01-29 |
1995-07-25 |
Mycogen Corporation |
Bacillus thuringiensisisolate PS201T6 toxin
|
|
RU2035186C1
(ru)
|
1992-07-09 |
1995-05-20 |
Семен Рафаилович Резник |
Профилактический биопрепарат споролакт
|
|
ATE200625T1
(de)
|
1992-10-09 |
2001-05-15 |
Advanced Tissue Sciences Inc |
Leberreservezellen
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
EP0952773B1
(en)
|
1995-09-15 |
2005-11-23 |
Dale N. Gerding |
Methods and compositions for prevention and treatment of clostridium difficile-associated diseases
|
|
AUPO430496A0
(en)
|
1996-12-19 |
1997-01-23 |
Arnott's Biscuits Limited |
Prebiotics and probiotics
|
|
US5965128A
(en)
|
1997-08-13 |
1999-10-12 |
University Of Georgia Research Foundation Inc. |
Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
|
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
US6589771B1
(en)
|
1999-10-28 |
2003-07-08 |
Immunom Technologies, Inc. |
Methods for arousing dormant bacteria
|
|
US20030118547A1
(en)
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
WO2001058465A2
(en)
|
2000-02-10 |
2001-08-16 |
Gregor Reid |
Probiotic therapy for newborns
|
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
IL156213A0
(en)
|
2000-11-30 |
2003-12-23 |
Bio Balance Corp |
Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
|
|
CN1678735A
(zh)
|
2001-05-04 |
2005-10-05 |
佛罗里达大学研究基金会有限公司 |
来源于细菌的丙酮酸脱羧酶(pdc)基因的克隆和测序及其用途
|
|
ITMI20011632A1
(it)
|
2001-07-27 |
2003-01-27 |
Sanofi Synthelabo |
Composizione solida contenente spore di batteri non patogeni del genere bacillus
|
|
GB0130789D0
(en)
|
2001-12-21 |
2002-02-06 |
King S College London |
Application of spores
|
|
US8383342B2
(en)
|
2002-04-24 |
2013-02-26 |
The University Of North Carolina At Greensboro |
Compositions, products, methods and systems to monitor water and other ecosystems
|
|
GB0212975D0
(en)
|
2002-06-06 |
2002-07-17 |
Mars Uk Ltd |
Mammalian animal composition
|
|
AU2002951692A0
(en)
|
2002-09-23 |
2002-10-17 |
Vital Biotech (Hong Kong) Limited |
Improvements in or relating to vaccines
|
|
AU2003303894A1
(en)
|
2003-01-30 |
2004-08-30 |
The Regents Of The University Of California |
Inactivated probiotic bacteria and methods of use thereof
|
|
CA2559596A1
(en)
|
2003-03-13 |
2004-11-25 |
Universite De Moncton (Bureau De Soutien A L'innovation) |
Antioxidant producing bacterium and uses thereof
|
|
DK1631312T3
(da)
|
2003-04-23 |
2009-01-19 |
Medarex Inc |
Sammensætning og fremstillingsmåde til behandling af inflammatorisk tarmsygdom
|
|
EP1473370A3
(en)
|
2003-04-24 |
2005-03-09 |
BioMerieux, Inc. |
Genus, group, species and/or strain specific 16S rDNA Sequences
|
|
WO2004104175A2
(en)
|
2003-05-14 |
2004-12-02 |
University Of Georgia Research Foundation, Inc. |
Probiotic bacteria and methods
|
|
JP2007518693A
(ja)
|
2003-08-18 |
2007-07-12 |
ザ バイオ バランス コーポレイション |
安定な液体プロバイオティクス組成物、その調製および適用
|
|
US7731976B2
(en)
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
|
US20050048515A1
(en)
|
2003-08-29 |
2005-03-03 |
Garner Bryan E. |
Methods for detecting and quantifying specific probiotic microorganisms in animal feed
|
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
HUE024565T2
(hu)
|
2004-02-03 |
2016-02-29 |
Prevtec Microbia Inc |
Élõ baktériumok alkalmazása növekedésserkentésre állatokban
|
|
US7632520B2
(en)
|
2004-02-16 |
2009-12-15 |
Sanjeev Khandelwal |
Synergistic antibacterial formulation and to a method of making the same
|
|
US7854927B2
(en)
|
2004-05-11 |
2010-12-21 |
Ganeden Biotech, Inc. |
Methods and compositions for the dietary management of autoimmune disorders
|
|
EP1812585B1
(en)
|
2004-11-01 |
2014-08-06 |
Erber Aktiengesellschaft |
Bacteriophages as selective agents
|
|
EP2280085A3
(en)
|
2004-11-01 |
2011-02-23 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
US20060188523A1
(en)
|
2005-01-10 |
2006-08-24 |
Zhiheng Pei |
Methods for diagnosing and treating chronic tonsillitis
|
|
US7993667B2
(en)
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
|
PL1885383T3
(pl)
|
2005-05-31 |
2017-06-30 |
Iams Europe B.V. |
Kocie probiotyczne bifidobakterie
|
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
|
DK3067057T3
(da)
*
|
2005-09-28 |
2023-02-13 |
Nordic Rebalance As |
Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier
|
|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
|
WO2007136553A2
(en)
|
2006-05-18 |
2007-11-29 |
Biobalance Llc |
Bacterial strains, compositions including same and probiotic use thereof
|
|
JP5019563B2
(ja)
|
2006-06-16 |
2012-09-05 |
旭化成ケミカルズ株式会社 |
腸内細菌賦活剤
|
|
JP2009541298A
(ja)
|
2006-06-20 |
2009-11-26 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
胃腸障害を処置するための電子カプセル
|
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
|
EE05459B1
(et)
|
2006-12-08 |
2011-08-15 |
Tartu �likool |
Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon
|
|
WO2008076696A2
(en)
|
2006-12-18 |
2008-06-26 |
Washington University In St. Louis |
The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
WO2008083157A2
(en)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
|
|
CA2699550C
(en)
|
2007-09-12 |
2020-08-18 |
Targanta Therapeutics Corp. |
Method of inhibiting clostridium difficile by administration of oritavancin
|
|
US8469648B2
(en)
*
|
2007-10-24 |
2013-06-25 |
T&T Engineering Services |
Apparatus and method for pre-loading of a main rotating structural member
|
|
JP2011503232A
(ja)
|
2007-11-20 |
2011-01-27 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
免疫応答の調節
|
|
US8236508B2
(en)
|
2008-01-29 |
2012-08-07 |
Drexel University |
Detecting and measuring live pathogens utilizing a mass detection device
|
|
US8021654B2
(en)
|
2008-03-14 |
2011-09-20 |
Danisco A/S |
Methods of treating pigs with Bacillus strains
|
|
JP2011527177A
(ja)
|
2008-04-01 |
2011-10-27 |
メタメトリックス クリニカル ラボラトリー |
胃腸微生物叢の監視プロセスおよび方法
|
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
|
CN102119330B
(zh)
|
2008-07-15 |
2014-02-12 |
梅坦诺米克斯保健有限公司 |
诊断胃改道手术及其相关状况的工具和方法
|
|
WO2010024251A1
(ja)
|
2008-08-26 |
2010-03-04 |
オリンパス株式会社 |
糞便試料の調製方法、糞便試料調製用溶液、及び採便用キット
|
|
WO2010030997A1
(en)
|
2008-09-12 |
2010-03-18 |
The Washington University |
Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss
|
|
WO2010036876A2
(en)
|
2008-09-25 |
2010-04-01 |
New York University |
Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota
|
|
CA2779413A1
(en)
|
2008-11-03 |
2010-06-03 |
Tufts University |
Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
IT1393931B1
(it)
|
2009-02-25 |
2012-05-17 |
Neuroscienze Pharmaness S C A R L |
Composizione di spore di batteri non patogeni
|
|
US20120128633A1
(en)
|
2009-04-30 |
2012-05-24 |
Campagnie Gervaise Donone |
Use of collinsella aerofaciens for reducing bloating
|
|
PL2419114T5
(pl)
|
2009-05-01 |
2019-09-30 |
Uas Laboratories Llc |
Kompozycje bakteryjne do profilaktyki i leczenia choroby degeneracyjnej
|
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
|
US20120264637A1
(en)
|
2009-06-26 |
2012-10-18 |
The Regents Of The University Of California |
Methods and systems for phylogenetic analysis
|
|
DK2446062T3
(da)
|
2009-06-26 |
2014-10-06 |
Univ California |
Fremgangsmåder og systemer til phylogenetisk analyse
|
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
|
CA2770099A1
(en)
|
2009-08-18 |
2011-02-24 |
Nestec S.A. |
A nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children.
|
|
WO2011022542A2
(en)
|
2009-08-19 |
2011-02-24 |
Puretech Ventures, Llc |
Administration of factors normally present in a microbial niche to improve health
|
|
US20120149584A1
(en)
|
2009-08-21 |
2012-06-14 |
Bernat Olle |
Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
|
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
JP2013505289A
(ja)
|
2009-09-23 |
2013-02-14 |
トーマス・ジュリアス・ボロディ |
腸管感染症の治療法
|
|
WO2011043654A1
(en)
|
2009-10-05 |
2011-04-14 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
|
WO2011046616A2
(en)
|
2009-10-15 |
2011-04-21 |
New York University |
Methods for modulating bacterial infection
|
|
WO2011060123A1
(en)
|
2009-11-12 |
2011-05-19 |
Nestec S.A. |
Nutritional composition for promoting gut microbiota balance and health
|
|
CA2785658C
(en)
|
2009-12-31 |
2017-10-24 |
Ira Milton Trachtman |
Compositions and method for treatment and prophylaxis of inflammatory bowel disease
|
|
HRP20220751T1
(hr)
|
2010-02-01 |
2022-09-02 |
Rebiotix, Inc. |
Bakterioterapija clostridium difficile kolitisa
|
|
US9492487B2
(en)
|
2010-02-01 |
2016-11-15 |
Matthew Ryan Garner |
Microbial product containing multiple microorganisms
|
|
WO2011103123A2
(en)
|
2010-02-16 |
2011-08-25 |
Arizona Technology Enterprises |
Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
|
|
AU2011223049B2
(en)
|
2010-03-01 |
2015-06-18 |
Institut National De La Recherche Agronomique |
Method of diagnostic of inflammatory bowel diseases
|
|
CN102939392A
(zh)
|
2010-03-01 |
2013-02-20 |
国家农艺研究院 |
肥胖的诊断方法
|
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
|
WO2011113801A1
(en)
|
2010-03-16 |
2011-09-22 |
Universiteit Gent |
Use of clostridium perfringens strain 23 to protect against necrotic enteritis
|
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
HRP20160805T1
(hr)
|
2010-07-06 |
2016-08-12 |
Glaxosmithkline Biologicals Sa |
Imuniziranje velikih sisavaca malim dozama rna
|
|
US9005601B2
(en)
|
2010-07-16 |
2015-04-14 |
The Board Of Trustees Of The University Of Arkansas |
Methods and compositions including spore-forming bacteria for increasing the health of animals
|
|
FI20105825A7
(fi)
|
2010-07-26 |
2012-01-27 |
Suomen Punainen Risti Veripalvelu |
Veriryhmästatuksen käyttö III
|
|
NZ607043A
(en)
|
2010-08-04 |
2015-05-29 |
Borody Thomas J |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2012033814A2
(en)
|
2010-09-10 |
2012-03-15 |
Viropharma Incorporated |
Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
|
|
AU2011313763A1
(en)
|
2010-10-04 |
2013-05-30 |
Emma Allen-Vercoe |
Detection of Fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
|
|
EP2637650A2
(en)
|
2010-11-10 |
2013-09-18 |
National Jewish Health |
Methods to test allergic conditions
|
|
US20120064592A1
(en)
|
2011-01-26 |
2012-03-15 |
Qteros, Inc. |
Biocatalysts synthesizing deregulated cellulases
|
|
CN103491969A
(zh)
|
2011-02-09 |
2014-01-01 |
拉维沃公司 |
恢复和重建肠道微生物群的合生素组合物
|
|
WO2012116289A2
(en)
|
2011-02-25 |
2012-08-30 |
Tricorder Diagnostics, Llc |
Microbial signatures as indicators of radiation exposure
|
|
WO2012122522A2
(en)
|
2011-03-09 |
2012-09-13 |
Washington University |
Cultured collection of gut microbial community
|
|
CN103561752B
(zh)
|
2011-03-09 |
2016-04-20 |
明尼苏达大学评议会 |
用于移植结肠微生物群的组合物和方法
|
|
WO2012142605A1
(en)
*
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
|
US20120276056A1
(en)
|
2011-04-26 |
2012-11-01 |
Wieslaw Janusz Bochenek |
Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine
|
|
WO2012159023A2
(en)
|
2011-05-19 |
2012-11-22 |
Virginia Commonwealth University |
Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
|
|
US9579353B2
(en)
|
2011-06-10 |
2017-02-28 |
Prothera, Inc. |
Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
|
|
US20130017999A1
(en)
|
2011-07-14 |
2013-01-17 |
Marc Fremont |
Methods and Compositions for Evaluating and/or Treating Chronic Immune Diseases
|
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
|
US20140348811A1
(en)
|
2011-07-27 |
2014-11-27 |
Max International, Llc |
Compositions comprising sugar-cysteine products
|
|
WO2013019896A1
(en)
|
2011-08-01 |
2013-02-07 |
Symbiotix Biotherapies, Inc. |
Platform for identifying and/or characterizing immunomodulatory agents
|
|
AU2012302364B2
(en)
|
2011-08-30 |
2016-07-28 |
Caelus Lifesciences IP B.V. |
Method for preventing and/or treating insulin resistance
|
|
US20140363397A1
(en)
|
2011-09-14 |
2014-12-11 |
Queen's University At Kingston |
Method for treatment of disorders of the gastrointestinal system
|
|
US20130121968A1
(en)
|
2011-10-03 |
2013-05-16 |
Atossa Genetics, Inc. |
Methods of combining metagenome and the metatranscriptome in multiplex profiles
|
|
WO2013066369A2
(en)
|
2011-10-03 |
2013-05-10 |
The Regents Of The University Of Michigan |
Methods for detecting graft-versus-host disease
|
|
GB201117313D0
(en)
*
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
WO2013053836A1
(en)
|
2011-10-11 |
2013-04-18 |
Quantum Pharmaceuticals Sa |
Composition comprising anaerobically cultivated human intestinal microbiota
|
|
US10238694B2
(en)
|
2011-12-01 |
2019-03-26 |
The University Of Tokyo |
Human-derived bacteria that induce proliferation or accumulation of regulatory T cells
|
|
GB201201766D0
(en)
|
2012-02-01 |
2012-03-14 |
Imp Innovations Ltd |
Method
|
|
WO2013166031A1
(en)
|
2012-04-30 |
2013-11-07 |
The Washington University |
Method of isolating and characterizing microorganisms that are targets of host immune responses
|
|
EP2850202B1
(en)
|
2012-05-18 |
2020-03-11 |
Genome Research Limited |
Methods and groups
|
|
WO2013176774A1
(en)
|
2012-05-25 |
2013-11-28 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
DK2854850T3
(da)
|
2012-05-25 |
2021-08-30 |
Sloan Kettering Inst Cancer Res |
Sammensætninger til behandling eller forebyggelse af strålingssygdom og gi-syndrom
|
|
EP2684469A1
(en)
|
2012-07-13 |
2014-01-15 |
Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO |
Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
EP3628161B1
(en)
|
2012-11-23 |
2023-04-05 |
Seres Therapeutics, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
WO2014121304A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Health, Inc. |
Compositions and methods
|
|
CA2899926C
(en)
|
2013-02-04 |
2025-11-18 |
Seres Therapeutics, Inc. |
DIGESTIVE TUBE FILLING COMPOSITIONS
|
|
HK1220495A1
(zh)
|
2013-03-14 |
2017-05-05 |
Seres Therapeutics, Inc. |
从材料和组合物中检测和富集病原体的方法
|
|
EP2967077A4
(en)
|
2013-03-15 |
2016-09-14 |
Seres Therapeutics Inc |
NETWORK-BASED MICROBIAL COMPOSITIONS AND METHOD
|
|
WO2014177667A1
(en)
|
2013-05-03 |
2014-11-06 |
Nestec S.A. |
Lachnospiraceae in the gut microbiota and association with body weight
|
|
WO2015018307A1
(en)
|
2013-08-06 |
2015-02-12 |
Bgi Shenzhen Co., Limited |
Biomarkers for colorectal cancer
|
|
MX367109B
(es)
|
2013-11-25 |
2019-08-05 |
Seres Therapeutics Inc |
Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
|
|
WO2015095241A2
(en)
|
2013-12-16 |
2015-06-25 |
Seres Health, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
RU2018103081A
(ru)
|
2015-07-08 |
2019-08-08 |
Серес Терапеутикс, Инк. |
Способы лечения колитов
|
|
US10300043B2
(en)
|
2015-08-12 |
2019-05-28 |
Mayo Foundation For Medical Education And Research |
Method for treating a gastrointestinal disorder in a mammal using bacteroides thetaiotaomicron and compositions thereof
|
|
WO2017074257A1
(en)
|
2015-10-26 |
2017-05-04 |
Nanyang Technological University |
Non-viable derivatives of clostridium sporogenes as anti-cancer therapeutic agents
|
|
KR20180083894A
(ko)
|
2015-11-24 |
2018-07-23 |
세레스 테라퓨틱스, 인코포레이티드 |
설계된 박테리아 조성물
|
|
EP3379935A4
(en)
|
2015-11-25 |
2019-08-28 |
Memorial Sloan-Kettering Cancer Center |
METHOD AND COMPOSITIONS FOR REDUCING VANCOMYCIN RESISTANT ENTEROKOKKEN
|
|
CA3008195A1
(en)
|
2015-12-14 |
2017-06-22 |
Metabogen Ab |
Treatment of intrahepatic cholestasis and related liver diseases
|
|
WO2017160711A1
(en)
|
2016-03-14 |
2017-09-21 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
|
AU2018346255A1
(en)
|
2017-10-03 |
2020-04-23 |
Seres Therapeutics, Inc. |
Manipulation of tryptamine metabolism
|
|
JP2021501185A
(ja)
|
2017-10-30 |
2021-01-14 |
セレス セラピューティクス インコーポレイテッド |
抗生物質耐性を処置するための組成物及び方法
|
|
MX2020012602A
(es)
|
2018-05-24 |
2021-03-31 |
Seres Therapeutics Inc |
Composiciones bacterianas dise?adas y usos de las mismas.
|